19 November 2026 Chair Address to Syntara Limited 2026 Annual General Meeting Dear Shareholders, It is my pleasure to address you at this year’s Annual General Meeting and to reflect on a year of clinical progress, strengthened regulatory positioning and continued financial discipline across the...
Chair's Address to Shareholders
Filed with ASX · · 2 pages · English
Release
In the deck
Earlier from Syntara
- Syntara Pauses SNT-9465 Phase 1b Recruitment
- Quarterly Activities/Appendix 4C Cash Flow Report
- Notice of Annual General Meeting/Proxy Form
- Investor Presentation Canaccord Drug & Device Conference
- Further significant results from SNT-4728 iRBD Phase 2 trial
Later from Syntara
All Syntara news releasesFollow Syntara into a list and get an email when it puts out news.
Follow Syntara